These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18566974)

  • 21. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
    Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
    Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of the neurokinin 1 receptor ligand [¹¹C]R116301.
    Wolfensberger SP; Maruyama K; van Berckel BN; Lubberink M; Airaksinen AJ; Boellaard R; Luurtsema G; Reddingius W; Janssens FE; Veltman DJ; Windhorst AD; Leysen JE; Lammertsma AA
    Nucl Med Commun; 2011 Oct; 32(10):896-902. PubMed ID: 21876400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents.
    Yamada K; Kobayashi M; Mori A; Jenner P; Kanda T
    Pharmacol Biochem Behav; 2013 Dec; 114-115():23-30. PubMed ID: 24201052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic analysis of [11C]vorozole binding in the human brain with positron emission tomography.
    Logan J; Kim SW; Pareto D; Telang F; Wang GJ; Fowler JS; Biegon A
    Mol Imaging; 2014; 13():1-12. PubMed ID: 24824855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy.
    Knauer CS; Campbell JE; Galvan B; Bowman C; Osgood S; Buist S; Buchholz L; Henry B; Wong EH; Shahid M; Grimwood S
    Eur J Pharmacol; 2008 Sep; 591(1-3):136-41. PubMed ID: 18593577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and ex vivo autoradiography studies on peripheral-type benzodiazepine receptor binding using [11C]AC-5216 in normal and kainic acid-lesioned rats.
    Yanamoto K; Zhang MR; Kumata K; Hatori A; Okada M; Suzuki K
    Neurosci Lett; 2007 Nov; 428(2-3):59-63. PubMed ID: 17959307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.
    Tavares AA; Batis J; Barret O; Alagille D; Vala C; Kudej G; Koren A; Cosgrove KP; Nice K; Kordower JH; Seibyl J; Tamagnan GD
    Nucl Med Biol; 2013 Apr; 40(3):403-9. PubMed ID: 23332393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-compartment description and kinetic procedure for measuring regional cerebral [11C]nomifensine uptake using positron emission tomography.
    Salmon E; Brooks DJ; Leenders KL; Turton DR; Hume SP; Cremer JE; Jones T; Frackowiak RS
    J Cereb Blood Flow Metab; 1990 May; 10(3):307-16. PubMed ID: 2329119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
    Renouard A; Widdowson PS; Millan MJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D1 receptor imaging in the rodent and primate brain using the isoquinoline +-[11C]A-69024 and positron emission tomography.
    Besret L; Dollé F; Hérard AS; Guillermier M; Demphel S; Hinnen F; Coulon C; Ottaviani M; Bottlaender M; Hantraye P; Kassiou M
    J Pharm Sci; 2008 Jul; 97(7):2811-9. PubMed ID: 17786986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-animal PET study of adenosine A(1) receptors in rat brain: blocking receptors and raising extracellular adenosine.
    Paul S; Khanapur S; Rybczynska AA; Kwizera C; Sijbesma JW; Ishiwata K; Willemsen AT; Elsinga PH; Dierckx RA; van Waarde A
    J Nucl Med; 2011 Aug; 52(8):1293-300. PubMed ID: 21764782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
    Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
    Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
    Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.
    Lingford-Hughes A; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; Nutt DJ
    J Cereb Blood Flow Metab; 2002 Jul; 22(7):878-89. PubMed ID: 12142573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of carbon-11-labeled KF17837: a potential CNS adenosine A2a receptor ligand.
    Noguchi J; Ishiwata K; Wakabayashi S; Nariai T; Shumiya S; Ishii S; Toyama H; Endo K; Suzuki F; Senda M
    J Nucl Med; 1998 Mar; 39(3):498-503. PubMed ID: 9529299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
    Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
    ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.
    Lehto J; Hirvonen MM; Johansson J; Kemppainen J; Luoto P; Naukkarinen T; Oikonen V; Arponen E; Rouru J; Sallinen J; Scheinin H; Vuorilehto L; Finnema SJ; Halldin C; Rinne JO; Scheinin M
    Synapse; 2015 Mar; 69(3):172-81. PubMed ID: 25530024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of [(11)C]yohimbine binding to α2 adrenoceptors in rat brain in vivo.
    Phan JA; Landau AM; Wong DF; Jakobsen S; Nahimi A; Doudet DJ; Gjedde A
    J Cereb Blood Flow Metab; 2015 Mar; 35(3):501-11. PubMed ID: 25564241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.